Moreover, kisspeptin-54 may be a substitute medication to trigger oocyte maturation during IVF treatment for women at high risk of developing ovarian hyperstimulation syndrome (67, 147, 148). The gene discussed is KISS1; the disease is ovarian hyperstimulation syndrome.